
Christina M. Madison, PharmD, FCCP, AAHIVP, sat down with Lydia Bailey, PharmD, BCACP, pharmacy operations manager at St. Vincent De Paul Charitable Pharmacy

Christina M. Madison, PharmD, FCCP, AAHIVP, sat down with Lydia Bailey, PharmD, BCACP, pharmacy operations manager at St. Vincent De Paul Charitable Pharmacy

This months generic product news includes Nitisinone capsules, Prednisolone tablets, Carboprost Tromethamine injections, and Methsuximide capsules.

These data support a paradigm shift in the treatment of locally advanced rectal cancer.

Despite the surge in new diabetes cases, the treatment options in in children remain limited.

For many patients with C diff, the experience of medical gaslighting is a common one because many health care providers lack education and familiarity with the disease.

Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.

Investigators said pre-exposure prophylaxis rollout is efficient in settings with high HIV incidence, but not in settings with low HIV incidence.

Inaccurate information, miscommunication during transition points can have dire consequences.

The findings could help in future vaccine prioritization strategies and therapeutic allocation policies for other pandemic.

Specialty pharmacists can have more contact with patients than providers.

Generic ketamine could cost as little as $5, which is significantly lower than the $800 per dose for the currently available S-ketamine nasal spray.

Due to the assessment of computerized tomography with criteria from 1999, the role of radiotherapy in patients with diffuse large B-cell lymphoma with bulky or extranodal disease remains undefined.

Patients with perinatally-acquired HIV reported low emotional, instrumental, and friendship support at 37%, 32%, and 36%, respectively.

Mobile apps can help consumers acquire medications, but few help with adherence beyond automatic refills or medication synchronization.

The 5-year survival rate for patients with exon 20 insertion EFGR mutation is 8% in the frontline setting, worse than the survival rate of the 2 most common types of EGFR mutations in patients with advanced or metastatic non-small cell lung cancer.

Participants were able to stop treatment after achieving amyloid plaque clearance and experience lasting results.

Neither of the 2 current standards of care offers patients a cure.

This months OTC products include brain fuel, SPF 50 mineral sunscreen, women's ensemble, and kids SPF 50 gentle lotion sunscreen.

Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.

Though the overall significance of the results were low, vitamin D was found to be especially useful in lowering the prevalence of myocardial infarction in older adults.

Pharmacist-led discharge stewardship initiatives have shown promising results.

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

A significant proportion of patients had negative hepatitis B surface antibody titers, indicating a need for vaccination to ensure protection for patients undergoing hemodialysis.

Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.

The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

With approximately 2 years of additional follow-up, lenvatinib plus pembrolizumab maintained robust effectiveness for nearly every patient.

High doses of intravenous immunoglobulin can result in expensive medical treatments for the families of children with immune thrombocytopenia.

Mounting concerns about availability of cancer drugs raise questions about the current supply